Atopic Dermatitis

Topical application of human breast milk has been deemed extremely beneficial for infants with atopic dermatitis.

Regeneron Pharmaceuticals, Inc. and Sanofi recently announced the US food and Drug Administration (FDA) granted Breakthrough Therapy designation to dupilumab, a fully-human monoclonal antibody, to treat adults suffering from moderate to severe atopic dermatitis (AD)who had an insufficient response to or who were not suitable for topical prescription therapy.

Atopic dermatitis is the most common inflammatory pediatric skin disorder, with reported incidences ranging from 10% to 20%. The principles of effect care include fixing the skin barrier, short-circuiting inflammation, decreasing itching, treating infections, and striving for prevention by addressing the triggers.

Session at Pri-Med Southwest focuses on diagnosing and treating atopic dermatitis and other conditions in children.

A defect in a deeper layer of the skin known as the "tight junctions" may play a key role in the development of atopic dermatitis.

Study shows demographic and geographic variability in prevalence, with higher rates among African Americans, city dwellers, and on the East Coast.

Review the recently published results of three studies that looked at atopic dermatitis in clinical practice.

Vaccine that incorporates nanoparticles filled with potent stimulators of the innate immune system proves promising in clinical trials.

Review findings from two recently published studies looking at imaging in atopic dermatitis.